Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Merrimack Pharmaceuticals ($MACK) could keep surging and here’s why
Is the recent price action on Nuvalent Inc (NUVL) justified
Hempacco Co (HPCO) turns heads on Wall Street post revenue surge
Wall Street set for another red day as rates surge on…
Senti Biosciences Inc (NASDAQ:SNTI) surges post CEO’s participation on Gene Regulation…
Finance
Applied DNA Sciences Inc (APDN) could keep surging and here’s why
Aeglea Bio Therapeutics Inc (NASDAQ: AGLE) Announces EMA Marketing Authorization Validation…
Why Your Body Needs Nitric Oxide Boost Beets For More Energy…
Top Beer Stocks for the Recession-Proof Portfolio (BUD, KEGS, SAM, TAP,…
Cutting Edge Power announces an all-new version of its popular Smart…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Biotech
Biotech
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Merrimack Pharmaceuticals ($MACK) could keep surging and here’s why
Kate Hudson
-
November 9, 2022
Is the recent price action on Nuvalent Inc (NUVL) justified
Hempacco Co (HPCO) turns heads on Wall Street post revenue surge
Wall Street set for another red day as rates surge on September’s jobs report (PFE, NVO,JNJ,MRK)
Senti Biosciences Inc (NASDAQ:SNTI) surges post CEO’s participation on Gene Regulation 
Revance Therapeutics Inc (NASDAQ:RVNC) surges while rest of the Wall Street...
Gavins Felicity
-
September 30, 2022
0
Aditxt Inc (NASDAQ:ADTX) surge is linked to its NASDAQ compliance requirement
Kate Hudson
-
September 13, 2022
0
Is NBIO a Take-Out Target as Phase 1 Brain Cancer Trial...
Matt Wade
-
September 13, 2022
0
Akero Therapeutics (NASDAQ:AKRO) surges when rest of the market crashes
Kate Hudson
-
September 13, 2022
0
Timber Pharmaceuticals Inc. (NYSEAMERICAN: TMBR) Announces Publication of Phase 2b CONTROL...
Gavins Felicity
-
September 5, 2022
0
Minerva Neurosciences Inc (NASDAQ: NERV) Submits New Drug Application for Roluperidone...
Gavins Felicity
-
September 2, 2022
0
Ginkgo Bioworks Holdings Inc (NYSE: DNA) Acquires Strategic Epidemiological Information Infrastructure...
Matt Wade
-
September 1, 2022
0
The US FDA Approves Axsome Therapeutics Inc’s (NASDAQ: AXSM) AUVELITY For...
Gavins Felicity
-
August 31, 2022
0
Palisade Bio Inc (NASDAQ: PALI) Commences Dosing Of Patients In Phase...
Gavins Felicity
-
August 30, 2022
0
Sorrento Therapeutics Inc (NASDAQ: SRNE) Receives NMPA Authorization of Phase 1...
Kate Hudson
-
August 29, 2022
0
1
2
3
...
159
Page 1 of 159
Recent Post
Airlines stocks look bearish post Covid (UAL,JBLU,MESA,ALK,ALGT)
Kate Hudson
-
November 29, 2022
0
After a weak day yesterday, the QQQ’s are testing yesterday’s low and are near the bottom of last week’s range. Apparently, we...
Grindr Inc (NYSE:GRND) technical setup looks bullish post merger
November 29, 2022
Recession-free stocks to place on top of radar (DG,TGT,DLTR,GOOG,BIG)
November 28, 2022
AMC Entertainment (AMC) looks poised for a Santa rally and here’s...
November 25, 2022
Market’s could rally into Thank Giving Friday (QQQ)
November 22, 2022
